This article provides a comprehensive, step-by-step guide for the phenotypic validation of CRISPR-Cas12a (Cpf1)-engineered cancer models.
This article provides a detailed examination of Cas12a (Cpf1) PAM requirements for target recognition, essential for researchers and drug development professionals.
This article provides a targeted analysis for researchers and biotech professionals on the genome editing efficiency of Cas12 and Cas9 systems in human cellular models.
This article provides a comprehensive analysis of the CTX310 clinical trial, a pioneering study investigating in vivo base editing of the ANGPTL3 gene for cardiovascular disease.
This article provides a comprehensive guide for researchers on applying CRISPR interference (CRISPRi) screening to investigate the functional roles of non-coding RNAs (ncRNAs).
This article provides a detailed scientific comparison of CRISPR activation (CRISPRa) and CRISPR interference (CRISPRi) technologies.
This comprehensive guide details the principles, methodologies, and applications of CRISPR activation (CRISPRa) and CRISPR interference (CRISPRi) technologies.
This article provides a comprehensive guide for researchers and drug developers on the application of CRISPR activation (CRISPRa) and CRISPR interference (CRISPRi) technologies in primary immune cells.
This comprehensive guide explores the cutting-edge applications and methodologies of CRISPR activation (CRISPRa) and CRISPR interference (CRISPRi) utilizing high-fidelity dead Cas9 (dCas9-HF) variants.
This article provides a detailed guide for constructing CRISPR-based double-knockout (CDKO) libraries, a powerful tool for high-throughput genetic interaction mapping and synthetic lethal screening.